SciTech Development

SciTech Development, LLC. is a clinical-stage biopharmaceutical company led by a team of NCI-affiliated and highly experienced senior drug and commercial development professionals. SciTech Development, LLC.'s clinical lead compound is an accelerated, short-course developmental anticancer agent (nano-fenretinide or ST-001) administered through a novel intravenous delivery system, initially for the treatment of orphan T-cell lymphoma, and subsequently for stem cell and other unmet need tumor types.